Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2.

Saved in:
Bibliographic Details
Title: Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2.
Authors: Azemar M; Tumor Biology Center, Freiburg, Germany., Djahansouzi S, Jäger E, Solbach C, Schmidt M, Maurer AB, Mross K, Unger C, von Minckwitz G, Dall P, Groner B, Wels WS
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2003 Dec; Vol. 82 (3), pp. 155-64.
Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print Cited Medium: Print ISSN: 0167-6806 (Print) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0167-6806
DOI:10.1023/b:brea.0000004371.48757.19